NMC
PIII icon

Nine Masts Capital’s P3 Health Partners PIII Stock Holding History

Nine Masts Capital’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.3K Buy
+17,964
New +$47.3K 0.01% 134

Other funds holding PIII

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Nine Masts Capital's PIII Position: Q1 2026 in Review

Nine Masts Capital opened a new position in P3 Health Partners (PIII) in Q1 2026: 17,964 shares worth $55.3K. The stake represents 0.01% of the portfolio and ranks #134 among its holdings.

17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • Nine Masts Capital held 17,964 shares of P3 Health Partners worth $55.3K as of Q1 2026.
  • P3 Health Partners was a new Nine Masts Capital position in Q1 2026.
  • P3 Health Partners made up 0.01% of Nine Masts Capital's portfolio in Q1 2026, its #134 holding.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on Nine Masts Capital's 13F filing for Q1 2026, filed 13 May 2026.